In vivo pre-treatment of tumour-derived dendritic cells with anti-CD40 agonist mAb results in therapeutic responses in resistant tumour models when used as vaccination strategies

Alexander Murgaski; Emile Clappaert; Máté Kiss; Cleo Goyvaerts; Damya Laoui

In vivo pre-treatment of tumour-derived dendritic cells with anti-CD40 agonist mAb results in therapeutic responses in resistant tumour models when used as vaccination strategies

Alexander Murgaski, Emile Clappaert, Máté Kiss, Cleo Goyvaerts, Damya Laoui

Research output: Unpublished contribution to conference › Poster

Original language	English
Publication status	Published - 18 Oct 2019
Event	ORC day 2019 - Duration: 18 Oct 2019 → 18 Oct 2019

Conference

Conference	ORC day 2019
Period	18/10/19 → 18/10/19

Cite this

@conference{08e7c9ffe3db4682af3d0976ea5eb831,

title = "In vivo pre-treatment of tumour-derived dendritic cells with anti-CD40 agonist mAb results in therapeutic responses in resistant tumour models when used as vaccination strategies",

author = "Alexander Murgaski and Emile Clappaert and M{\'a}t{\'e} Kiss and Cleo Goyvaerts and Damya Laoui",

year = "2019",

month = "10",

day = "18",

language = "English",

note = "ORC day 2019 ; Conference date: 18-10-2019 Through 18-10-2019",

}

In vivo pre-treatment of tumour-derived dendritic cells with anti-CD40 agonist mAb results in therapeutic responses in resistant tumour models when used as vaccination strategies. / Murgaski, Alexander ; Clappaert, Emile ; Kiss, Máté ; Goyvaerts, Cleo ; Laoui, Damya.

2019. Poster session presented at ORC day 2019, .

Research output: Unpublished contribution to conference › Poster